Atlas FDA

DEFLUX INJECTABLE GEL

FDA premarket approval P000029/S021 · decided 2008-07-21

Approval details

PMA number
P000029
Supplement
S021
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
DEFLUX INJECTABLE GEL
Generic name
AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE
Applicant
Palette Life Sciences
Date received
2007-03-05
Decision date
2008-07-21
Days to decision
504 days
Decision code
APPR
Product code
LNM
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Santa Barbara, CA
Statement
APPROVAL FOR A CHANGE IN THE SOURCE OF DEXTRANOMER MATERIAL USED TO MANUFACTURE DEFLUX INJECTABLE GEL FROM DX-10 TO DX.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Barrigel Injectable Gel (K220641)Palette Life Sciences2022-05-26